1. |
Aktaş G, Bertizlioglu M, Yılmaz SA, et al. Follicle-Stimulating Hormone Receptor and Estrogen Receptor Gene Polymorphisms in Women With Discordant Follicle-Stimulating Hormone and Anti-Mullerian Hormone Levels. Cureus, 2024, 16(5): e60446.
DOI:10.7759/cureus.60446
|
2. |
Miedl H, Oswald D, Haslinger I, et al. Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and Prognosis of Breast Cancer. Cells, 2023, 12(4): 515.
DOI:10.3390/cells12040515
|
3. |
Khorshid Shamshiri A, Alidoust M, Hemmati Nokandei M, et al. Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review. Clin Transl Oncol, 2023, 25(6): 1729-1747.
DOI:10.1007/s12094-022-03071-8
|
4. |
Allahloubi NMA, Zekri AN, Ragab M, et al. Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients. Biochem Genet, 2022, 60(6): 1963-1985.
DOI:10.1007/s10528-022-10199-3
|
5. |
Kasielska-Trojan A, Pietrusiński M, Bugaj-Tobiasz M, et al. Genetic Factors of Idiopathic Gigantomastia: Clinical Implications of Aromatase and Progesterone Receptor Polymorphisms. J Clin Med, 2022, 11(3): 642.
DOI:10.3390/jcm11030642
|
6. |
Karsono R, Haryono SJ, Karsono B, et al. ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer. BMC Cancer, 2021, 21(1): 1348.
DOI:10.1186/s12885-021-09083-x
|
7. |
Tan SC, Low TY, Mohamad Hanif EA, et al. The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility. Sci Rep, 2021, 11(1): 18619.
DOI:10.1038/s41598-021-97935-8
|
8. |
Lukina SS, Burdennyy AM, Zavarykina TM, et al. The Role of ESR1 Gene Polymorphic Markers in the Development of Breast Cancer and Resistance to Tamoxifen Therapy. Bull Exp Biol Med, 2021, 170(3): 350-355.
DOI:10.1007/s10517-021-05065-y
|
9. |
Al-Amri RJ, Alotibi MKH, Al-Raddadi RI, et al. Estrogen Receptor 1 Gene (ESR1) rs2234693 Polymorphism and Breast Cancer Risk in Saudi Women. Asian Pac J Cancer Prev, 2020, 21(11): 3235-3240.
DOI:10.31557/APJCP.2020.21.11.3235
|
10. |
Sartor H, Brandt J, Grassmann F, et al. The association of single nucleotide polymorphisms (SNPs) with breast density and breast cancer survival: the Malmö Diet and Cancer Study. Acta Radiol, 2020, 61(10): 1326-1334.
DOI:10.1177/0284185119900436
|
11. |
Kasielska-Trojan A, Danilewicz M, Strużyna J, et al. The role of oestrogen and progesterone receptors in gigantomastia. Arch Med Sci, 2019, 18(4): 1016-1020.
DOI:10.5114/aoms.2019.88280
|
12. |
Al-Eitan LN, Rababa'h DM, Alghamdi MA, et al. Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC Cancer, 2019, 19(1): 1257.
DOI:10.1186/s12885-019-6490-7
|
13. |
Pinkas J, Bojar I, Gujski M, et al. Effect of interactions between APOE and ESR1 polymorphisms on cognitive functions in postmenopausal women. Arch Med Sci, 2018, 17(1): 31-39.
DOI:10.5114/aoms.2018.72972
|
14. |
Pontin PA, Nogara PRB, Fonseca FCP, et al. ERα PvuII and XbaI polymorphisms in postmenopausal women with posterior tibial tendon dysfunction: a case control study. J Orthop Surg Res, 2018, 13(1): 316.
DOI:10.1186/s13018-018-1020-x
|
15. |
Zhang ZL, Zhang CZ, Li Y, et al. Association between ERα gene Pvu II polymorphism and breast cancer susceptibility: A meta-analysis. Medicine (Baltimore), 2018, 97(17): e0317.
DOI:10.1097/MD.0000000000010317
|